Back and forth

Close metadata

Gastroesophageal reflux disease.

Authors:

Kaibysheva V.O.

MD, PhD, Gastroenterologist, Senior Research Fellow, Hospital Surgery Department No.2, N.I. Pirogov Russian Medical University, Moscow Municipal Clinical Hospital No.31

ORCID: 0000-0003-0114-3700

Kagarmanova E.M.

M.D., doctor of the highest category, head of the gastroenterological department of the Republican Clinical Hospital No. 21, chief freelance specialist-gastroenterologist of the Ministry of Health of the Republic of Bashkortostan

List of references:

Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022 Jan 1;117(1):27–56. doi: 10.14309/ajg.0000000000001538.
Ивашкин В. Т., Маев И. В., Трухманов А. С., Лапина Т. Л., Сторонова О. А., Зайратьянц О. В., Дронова О. Б., Кучерявый Ю. А., Пирогов С. С., Сайфутдинов Р. Г., Успенский Ю. П., Шептулин А. А., Андреев Д. Н., Румянцева Д. Е. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению гастроэзофагеальной рефлюксной болезни. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2020;30(4):70–97. doi: 10.22416/1382–4376–2020–30–4–70–97.
Кайбышева В. О., Морозов С. В., Исаков В. А., Шаповальянц С. Г. Диагностика гастроэзофагеальной рефлюксной болезни: роль и значение манометрии пищевода высокого разрешения. Экспериментальная и клиническая гастроэнтерология. 2018;158(10):10–21. doi: 10.31146/1682–8658-ecg‑158–10–10–21.
Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM, Vaezi M, Sifrim D, Fox MR, Vela MF, Tutuian R, Tack J, Bredenoord AJ, Pandolfino J, Roman S. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018 Jul;67(7):1351–1362. doi: 10.1136/gutjnl‑2017–314722.
Yadlapati R, Gyawali CP, Pandolfino JE; CGIT GERD Consensus Conference Participants. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review. Clin Gastroenterol Hepatol. 2022 May;20(5):984–994.e1. doi: 10.1016/j.cgh.2022.01.025.
Rodríguez-de-Santiago E, Frazzoni L, Fuccio L, van Hooft JE, Ponchon T, Hassan C, Dinis-Ribeiro M. Digestive findings that do not require endoscopic surveillance – Reducing the burden of care: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2020 Jun;52(6):491–497. doi: 10.1055/a‑1137–4721.
Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, Jankowski JA, Junghard O, Lundell L, Tytgat GN, Vieth M. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006 Nov;131(5):1392–9. doi: 10.1053/j.gastro.2006.08.032.
Кайбышева В. О., Шаповальянц С. Г. Роль функциональных методов исследования в диагностике и выборе лечения гастроэзофагеальной рефлюксной болезни и ее осложнений. Доказательная гастроэнтерология. 2017;3:9–18. doi: 10.17116/dokgastro2017639–18.
Кайбышева В. О., Кашин С. В., Карасев А. В., Меркулова А. О., Крайнова Е. А., Федоров Е. Д., Шаповальянц С. Г. Пищевод Барретта: современное состояние проблемы. Доказательная гастроэнтерология. 2020;9(4):33–54. doi: 10.17116/dokgastro2020904133.
El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008 Sep;53(9):2307–12. doi: 10.1007/s10620–008–0413–9.
Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005 Aug 2;143(3):199–211. doi: 10.7326/0003–4819–143–3–200508020–00006.
Морозов С. В., Кучерявый Ю. А., Кукушкина М. Д. Роль дефицита пищевых волокон в развитии проявлений и течении гастроэзофагеальной рефлюксной болезни. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2013;1(2):6–13.
Wang WH, Huang JQ, Zheng GF, Xia HH, Wong WM, Lam SK, Wong BC. Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis. World J Gastroenterol. 2005 Jul 14;11(26):4067–77. doi: 10.3748/wjg.v11.i26.4067.
Khan M, Santana J, Donnellan C, Preston C, Moayyedi P. Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev. 2007 Apr 18;(2): CD003244. doi: 10.1002/14651858.CD003244.pub2.
Robinson M, Sahba B, Avner D, Jhala N, Greski-Rose PA, Jennings DE. A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group. Aliment Pharmacol Ther. 1995 Feb;9(1):25–31. doi: 10.1111/j.1365–2036.1995.tb00347.x.
Kirchheiner J, Glatt S, Fuhr U, Klotz U, Meineke I, Seufferlein T, Brockmöller J. Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH. Eur J Clin Pharmacol. 2009 Jan;65(1):19–31. doi: 10.1007/s00228–008–0576–5.
Graham DY, Tansel A. Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency. Clin Gastroenterol Hepatol. 2018 Jun;16(6):800–808.e7. doi: 10.1016/j.cgh.2017.09.033.
Grossi L, Spezzaferro M, Sacco LF, Marzio L. Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study. Neurogastroenterol Motil. 2008 Jul;20(7):760–6. doi: 10.1111/j.1365–2982.2008.01115.x.
Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut. 2003 Oct;52(10):1397–402. doi: 10.1136/gut.52.10.1397.
Vela MF, Tutuian R, Katz PO, Castell DO. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther. 2003 Jan;17(2):243–51. doi: 10.1046/j.1365–2036.2003.01394.x.
Scarpellini E, Vos R, Blondeau K, Boecxstaens V, Farré R, Gasbarrini A, Tack J. The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man. Aliment Pharmacol Ther. 2011 Jan;33(1):99–105. doi: 10.1111/j.1365–2036.2010.04487.x.
Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010 Jan;31(1):11–9. doi: 10.1111/j.1365–2036.2009.04189.x.
Ren LH, Chen WX, Qian LJ, Li S, Gu M, Shi RH. Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis. World J Gastroenterol. 2014 Mar 7;20(9):2412–9. doi: 10.3748/wjg.v20.i9.2412.
Xi L, Zhu J, Zhang H, Muktiali M, Li Y, Wu A. The treatment efficacy of adding prokinetics to PPIs for gastroesophageal reflux disease: a meta-analysis. Esophagus. 2021 Jan;18(1):144–151. doi: 10.1007/s10388–020–00753–6.
Jung DH, Huh CW, Lee SK, Park JC, Shin SK, Lee YC. A Systematic Review and Meta-analysis of Randomized Control Trials: Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease. J Neurogastroenterol Motil. 2021 Apr 30;27(2):165–175. doi: 10.5056/jnm20161.

Close metadata